HUNAN DAJIAWEIKANG PHARMACEUTICAL INDUSTRY CO.,LTD

News Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

Equities

301126

CNE1000054V3

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-22 EDT			5-day change	1st Jan Change
9.81 ^CNY	-7.19%		-3.06%	-24.71%

04-22	Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-28	Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 119.999994 million in funding	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-22	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 119.999994 million in funding	03-27	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Board Elections	23-10-11	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd signed the share acquisition agreement to acquire 51% stake in Shanxi Simaile Pharmaceutical Chain Co., Ltd. from Yang Jinjiang, Liu Hongming for approximately CNY 330 million.	23-09-18	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd agreed to acquire Yinchuan Meihetai Pharmaceutical Chain Co., Ltd. from Xie Huiyang and Xie Xiaolong for approximately CNY 250 million.	23-07-03	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Implements Final Cash Dividend of A Shares for the Year 2022, Payable on June 12, 2023	23-06-02	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Final Cash Dividend for 2022	23-05-15	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd cancelled the transaction announced on May 18, 2022	23-04-27	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 300 million in funding	23-04-27	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Proposes Final Cash Dividend for the Year 2022	23-04-24	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-21	CI
Hunan Tongjian Pharmacy to Buy 86% Stake in Local Peer For 341 Million Yuan	23-01-03	MT
Hunan Tongjian Pharma to Buy 86% of Local TCM Maker For 341 Million Yuan	22-12-22	MT
Certain A Shares of Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd. are subject to a Lock-Up Agreement Ending on 8-DEC-2022.	22-12-07	CI
Hunan Dajiaweikang Pharma to Buy 85.7% Stake in Pharma Firm	22-11-16	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd signed a Share Transfer Agreement to acquire a 85.7143% stake in Hunan Tianjicaotang Pharmaceutical CO.,LTD. from Weng Xiaotao and Xiang Zhongyou for CNY 340 million.	22-11-15	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd completed the acquisition of 51% stake in Ningxia Delixin Medicine Co., Ltd. from Duan Junzhang, Duan Xisheng and Zhao Xupeng.	22-08-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

Equities

301126

CNE1000054V3

Summary

Filters